NEOPLASMS BY SITE

Clinical trials for NEOPLASMS BY SITE explained in plain language.

Never miss a new study

Get alerted when new NEOPLASMS BY SITE trials appear

Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 7 Completed 4 Terminated 3

Could existing cancer drugs tackle rare tumors? new trial aims to find out

Disease control Not yet recruiting

This trial tests whether two approved drugs, dabrafenib and trametinib, can treat rare cancers that have a specific genetic change called BRAF V600. These drugs are already used for melanoma and lung cancer, but researchers want to see if they help people with other cancer types.…

Matched conditions: NEOPLASMS BY SITE

Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control

Last updated Jun 27, 2026 09:09 UTC

NEOPLASMS BY SITE

Get alerted when new NEOPLASMS BY SITE trials appear

Could existing cancer drugs tackle rare tumors? new trial aims to find out